GILD
Gilead Sciences Inc
150.10$
-0.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +65.8% | -19.8% | -30.2% | -29.4% | +8.9% | -10.7% | +39.4% | -20.3% | -11.8% | +35.2% | -7.5% | |
| – | +4.6% | +5.5% | +11.1% | +11.1% | -1.7% | +5.4% | +38.5% | +2.6% | +28.1% | +2.7% | -0.3% | |
| – | +6.1% | -0.5% | +67.9% | +32.4% | -24.7% | +1.1% | -1.2% | +0.3% | +20.3% | +9.0% | +7.1% | |
| – | – | – | +81.1% | +133.7% | -123.8% | – | +74.2% | -69.2% | – | – | – | |
| – | – | +3.4% | +230.4% | -118.4% | – | – | – | -460.5% | – | – | – | |
| – | +34.1% | +0.1% | -21.1% | +56.6% | -10.7% | -21.2% | -10.9% | +25.7% | -19.6% | -10.6% | +7.6% | |
| – | +584.3% | -3.9% | +34.1% | – | -154.5% | +87.0% | -78.6% | -21.2% | -8.2% | +52.3% | +39.0% | |
| – | -70.6% | +31.0% | +11.2% | +8.8% | +8.4% | +7.0% | +4.5% | +2.9% | +2.7% | +2.9% | +2.2% | |
| – | +87.0% | +10.0% | -91.3% | +204.0% | -39.7% | -9.5% | -65.5% | +155.7% | -28.4% | +15.0% | +67.1% | |
| – | +70.1% | -56.0% | +68.1% | -187.1% | -56.0% | – | -183.6% | -68.4% | -82.0% | – | -219.7% | |
| – | +94.5% | +65.3% | – | -463.0% | -38.0% | – | -1,252.9% | -27.1% | -20.8% | -33.0% | +125.6% | |
| – | -64.3% | -263.7% | – | – | -160.9% | – | – | – | +809.5% | +480.4% | -162.1% | |
| – | +67.2% | -20.5% | -30.6% | -33.9% | +11.3% | -9.6% | +43.7% | -22.8% | -11.1% | +38.9% | -8.2% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.